Fresenius Kabi Compounding, LLC recalls NORepinephrine Bitartrate 0.9% Sodium Chloride Injection USP
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- cGMP violations
- Products
-
- NORepinephrine Bitartrate 0.9% Sodium Chloride Injection USP
- Where it was sold
-
Product was distributed to 125 direct accounts nationwide.
Nationwide
- Units affected
- 2151 bags
- About this recall
- NORepinephrine Bitartrate 0.9% Sodium Chloride Injection USP, 4 mg per 250 mL, Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC: 71506-025-58